Omzet 2024 * | 2,72 mld. 10,06 mld. 2,52 mld. | Omzet 2025 * | 3,05 mld. 11,28 mld. 2,82 mld. | Marktkapitalisatie | 14,3 mld. 52,83 mld. 13,22 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 439 mln. 1,62 mld. 406 mln. | Nettowinst (verlies) 2025 * | 528 mln. 1,95 mld. 488 mln. | EV/omzet 2024 * | 4,77 x |
Nettoliquiditeiten 2024 * | 1,32 mld. 4,86 mld. 1,22 mld. | Nettoliquiditeiten 2025 * | 2,15 mld. 7,95 mld. 1,99 mld. | EV/omzet 2025 * | 3,98 x |
K/w-verhouding 2024 * |
34,6
x | K/w-verhouding 2025 * |
28,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,00% | 85,03 mld. | |
+3,81% | 77,41 mld. | |
-13,71% | 53,89 mld. | |
-22,50% | 47,59 mld. | |
+24,52% | 46,63 mld. | |
+19,05% | 42,81 mld. | |
+66,02% | 37,02 mld. | |
-10,16% | 24,56 mld. | |
+18,57% | 21,72 mld. |